RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
US Neurosurgical Holdings Stock

US Neurosurgical Holdings ROA 2024

US Neurosurgical Holdings ROA

-0.62

Ticker

USNU

ISIN

US90336K1016

In 2024, US Neurosurgical Holdings's return on assets (ROA) was -0.62, a -19.29% increase from the -0.77 ROA in the previous year.

US Neurosurgical Holdings Aktienanalyse

What does US Neurosurgical Holdings do?

US Neurosurgical Holdings Inc (USN) is a diversified medical company that specializes in the development and marketing of innovative neurosurgical instruments and devices to improve patient care. History: The company's history dates back to 1996 when USN was founded to meet market needs in neurosurgical device supply. With a focus on quality, innovation, and customer satisfaction, USN became a pioneer in neurosurgical instruments and devices. Business model: USN's business model focuses on the manufacturing and marketing of products and services in the field of neurosurgical devices and instruments. The company aims to meet the needs of customers in this area and build long-term partnerships with them. The company works directly with customers such as neurosurgeons, hospitals, medical facilities, and healthcare institutions to ensure effective delivery of products and services. Divisions: USN operates multiple business divisions tailored to the needs of the healthcare sector. These include: 1. Neurosurgical instruments: USN offers a wide range of neurosurgical instruments that can be used for diagnostic or therapeutic work. The products include specialized microscopes, standard and custom instruments, as well as devices for spinal or brain surgery. The instruments are made of high-quality materials and meet the highest quality standards. 2. Neurodiagnostic equipment: Neurological examinations are essential for achieving good results. USN has a variety of biomedical devices used in this field, such as measurement probes, EEG equipment, IT systems, patient monitoring solutions, etc. 3. Neuro-implants: USN also offers a range of implants that can be used to treat various neurological impairments. These include ventriculoperitoneal shunts or hair-like implants. Products: USN offers a wide range of products, including: 1. Neurosurgical instruments: The company offers various types of neurosurgical instruments, including microscopes, standard and custom instruments. Popular products include standard and custom instrument sets used to support neurosurgical procedures. These sets are developed in close collaboration with neurosurgeons and other healthcare providers. 2. Neurodiagnostic equipment: USN offers a wide range of neurodiagnostic products, such as measurement probes, EEG equipment, IT systems, patient monitoring solutions, which can be used in various areas of the healthcare sector. 3. Neuro-implants: USN also offers a range of implants, including ventriculoperitoneal shunts for treating normal pressure hydrocephalus or implants that mimic the shape of hair. These implants are used to treat various neurological disorders. Conclusion: US Neurosurgical Holdings is a pioneer in neurosurgical device supply and has established itself as a significant industry leader. With a wide range of products and services, the company is well-positioned to meet the needs of customers in the healthcare sector. USN's focus on quality and customer satisfaction has made it the choice for many healthcare providers in need of state-of-the-art neurosurgical devices and instruments. US Neurosurgical Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding US Neurosurgical Holdings's Return on Assets (ROA)

US Neurosurgical Holdings's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing US Neurosurgical Holdings's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider US Neurosurgical Holdings's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in US Neurosurgical Holdings’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about US Neurosurgical Holdings stock

What is the Return on Assets (ROA) of US Neurosurgical Holdings this year?

The Return on Assets (ROA) of US Neurosurgical Holdings is -0.62 undefined this year.

What was the ROA of US Neurosurgical Holdings compared to the previous year?

The ROA of US Neurosurgical Holdings has increased by -19.29% compared to the previous year.

What consequences do high ROA have for investors of US Neurosurgical Holdings?

A high ROA is advantageous for investors of US Neurosurgical Holdings, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in US Neurosurgical Holdings?

A low ROA can be unfavorable for investors of US Neurosurgical Holdings as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of US Neurosurgical Holdings affect the company?

An increase in ROA of US Neurosurgical Holdings can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of US Neurosurgical Holdings impact the company?

A reduction in the ROA of US Neurosurgical Holdings can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of US Neurosurgical Holdings?

Some factors that can influence the ROA of US Neurosurgical Holdings include revenue, operating costs, asset structure, and industry average.

Why is the ROA of US Neurosurgical Holdings important for investors?

The ROA of US Neurosurgical Holdings is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can US Neurosurgical Holdings take to improve ROA?

To improve ROA, US Neurosurgical Holdings can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does US Neurosurgical Holdings pay?

Over the past 12 months, US Neurosurgical Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, US Neurosurgical Holdings is expected to pay a dividend of 0 USD.

What is the dividend yield of US Neurosurgical Holdings?

The current dividend yield of US Neurosurgical Holdings is .

When does US Neurosurgical Holdings pay dividends?

US Neurosurgical Holdings pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of US Neurosurgical Holdings?

US Neurosurgical Holdings paid dividends every year for the past 0 years.

What is the dividend of US Neurosurgical Holdings?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is US Neurosurgical Holdings located?

US Neurosurgical Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von US Neurosurgical Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of US Neurosurgical Holdings from 9/29/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/29/2024.

When did US Neurosurgical Holdings pay the last dividend?

The last dividend was paid out on 9/29/2024.

What was the dividend of US Neurosurgical Holdings in the year 2023?

In the year 2023, US Neurosurgical Holdings distributed 0 USD as dividends.

In which currency does US Neurosurgical Holdings pay out the dividend?

The dividends of US Neurosurgical Holdings are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von US Neurosurgical Holdings

Our stock analysis for US Neurosurgical Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of US Neurosurgical Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.